hemophilia

First Opinion By Joe Lieberman and Michelle McMurry-Heath

Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures

Health By Rachel Cohrs

What happens when the government stops buying Covid-19 vaccines?

Hospitals By Tara Bannow

Life or death decisions and no feedback: New study highlights the value of patient tracking, especially in the ER

Pharmalot By Ed Silverman

Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program

Health Tech By Casey Ross

Google taps FDA’s former digital health chief for global strategy role

Health By Jason Mast

FDA rejects antidepressant seen as possible Covid-19 treatment

Biotech By Allison DeAngelis

Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences

By STAT

The need for speed and safety: A primer on the FDA’s drug approval pathways